P1000: JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML) INHIBITS T CELL PROLIFERATION VIA THE ECTONUCLEOTIDASE CD39 AND THE PURINERGIC NETWORK by Jovana Rajak, Naile Koleci, Andreea Mesesan, Christian Flotho, Charlotte Niemeyer, Bertram Bengsch, Miriam Erlacher

Get full text

THE INTERFACE OF EPIGENETICS AND ENERGY METABOLISM IN JUVENILE MYELOMONOCYTIC LEUKEMIA by Zoé Wehbe, Ruba Hammad, Toni Cathomen, Sheila Bohler, Jovana Rajak, Miriam Erlacher, Foued Ghanjati, Charlotte Niemeyer, Christian Flotho

Get full text

INVESTIGATING AND MODULATING LEUKEMIA INITIATING CELLS TO REDUCE RISK OF POST-TRANSPLANT RELAPSE IN JMML by Hui Xiao, Naile Koleci, Jun Wang, Jovana Rajak, Niels Anton Wehner, Sheila Bohler, Juncal Fernandez Orth, Charlotte M. Niemeyer, Miriam Erlacher

Get full text

JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML) CELLS ESCAPE IMMUNE SURVEILLANCE BY MULTIPLE MECHANISMS by Jun Wang, Jovana Rajak, Naile Koleci, Hui Xiao, Anton Niels Wehner, Bertram Bengsch, Juncal Fernandez-Orth, Charlotte Niemeyer, Sheila Bohler, Miriam Erlacher

Get full text

PUMA-INDUCED APOPTOSIS DRIVES BONE MARROW FAILURE UPON TELOMERE SHORTENING AND LEUKEMIA IN A MOUSE MODEL OF DYSKERATOSIS CONGENITA by Christian Molnar, Sheila Bohler, Jovana Rajak, Julia Miriam Weiss, Irene Gonzalez-Mendez, Geoffroy Andrieux, Eva-Maria Demmerath, Madeleine Wahl, Lena Wendeburg, Gudrun Göhring, Brigitte Strahm, Doris Steinemann, Martina Rudelius, Melanie Börries, Leticia Quintanilla-Martinez, Charlotte M. Niemeyer, Verena Labi, Miriam Erlacher

Get full text

ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT by Mark Hartmann, Maximilian Schönung, Jovana Rajak, Joschka Hey, Valentin Maurer, Ling Hai, Sina Staeble, Jens Langstein, Katharina Bauer, Mariam Hakobyan, Laura Jardine, Sheila Bohler, Dominik Vonficht, Abdul-Habib Maag, Dirk Lebrecht, Katrin M. Bernt, Roland Roelz, Tobias Boch, Eleonora Khabirova, Pavlo Lutsik, Simon Haas, Muzlifah Haniffa, Sam Behjati, Jan-Philipp Mallm, Christian Buske, Michael D. Milsom, Stefan Fröhling, Marc-Jan Bonder, Charlotte Niemeyer, Christian Flotho, Christoph Plass, Miriam Erlacher, Matthias Schlesner, Daniel B. Lipka

Get full text

S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT by Mark Hartmann, Maximilian Schönung, Jovana Rajak, Joschka Hey, Valentin Maurer, Ling Hai, Sina Staeble, Jens Langstein, Katharina Bauer, Mariam Hakobyan, Laura Jardine, Sheila Bohler, Dominik Vonficht, Abdul-Habib Maag, Dirk Lebrecht, Kathrin Bernt, Roland Rölz, Tobias Boch, Eleonora Khabirova, Pavlo Lutsik, Simon Haas, Muzlifah Haniffa, Sam Behjati, Jan-Philipp Mallm, Christian Buske, Michael Milsom, Stefan Fröhling, Marc-Jan Bonder, Christoph Plass, Charlotte Niemeyer, Christian Flotho, Miriam Erlacher, Matthias Schlesner, Daniel B. Lipka

Get full text